Catherine Novack
Stock Analyst at Jones Trading
(2.59)
# 2,128
Out of 5,150 analysts
24
Total ratings
31.58%
Success rate
10.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBIO iBio, Inc. | Initiates: Buy | $7 | $2.70 | +159.26% | 1 | Mar 3, 2026 | |
| SEPN Septerna | Initiates: Buy | $43 | $28.04 | +53.35% | 1 | Dec 23, 2025 | |
| KRRO Korro Bio | Downgrades: Hold | n/a | $11.27 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $5.02 | +558.03% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $14.45 | +107.61% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $26.35 | +10.06% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.53 | +1,029.52% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $11.23 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $137.15 | -67.19% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.59 | +591.82% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.82 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $13.47 | +18.78% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $5.53 | +153.16% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.56 | +733.33% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.25 | +208.17% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $0.58 | +3,693.76% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.17 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,600 | $4.72 | +33,798.31% | 1 | Jul 21, 2023 |
iBio, Inc.
Mar 3, 2026
Initiates: Buy
Price Target: $7
Current: $2.70
Upside: +159.26%
Septerna
Dec 23, 2025
Initiates: Buy
Price Target: $43
Current: $28.04
Upside: +53.35%
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $11.27
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $5.02
Upside: +558.03%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $14.45
Upside: +107.61%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $26.35
Upside: +10.06%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.53
Upside: +1,029.52%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $11.23
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $137.15
Upside: -67.19%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.59
Upside: +591.82%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.82
Upside: -
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $13.47
Upside: +18.78%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $5.53
Upside: +153.16%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.56
Upside: +733.33%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $3.25
Upside: +208.17%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $0.58
Upside: +3,693.76%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $7.17
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $1,600
Current: $4.72
Upside: +33,798.31%